When men with prostate cancer have to take drugs that block the testosterone fueling their tumors, they can suffer a host of side effects that include impotence, bone loss, heart trouble and obesity. But new research uncovers yet another possible downside to the treatment: These men may be at greater risk for dementia. For any type of dementia, that risk increased 17%; for Alzheimer’s disease, it increased 23%, the researchers said. Common side effects of so-called androgen-deprivation therapy include hot flashes, unstable mood, trouble sleeping, headaches, high blood sugar, allergic reactions and impotence. “Androgen-deprivation therapy may not only cause physical changes — such as osteoporosis, cardiovascular disease or obesity — but may also cause changes in cognition,” said researcher Dr. Karl Tully, a research fellow at Brigham and Women’s Hospital in Boston. But Tully cautioned that this study cannot prove that such hormone therapy caused dementia, only that the two are associated. The investigators also found that men on this type of therapy had a 10% greater risk of seeking psychiatric services. The risk for dementia increased as the length of therapy increased, the researchers noted. Men on androgen-deprivation therapy for six months had a 25% increased risk for any kind of dementia and a 37% increased risk for Alzheimer’s, the findings showed. Being on hormone therapy longer than six months increased the risk for… read on >

















